Development of a High‐Throughput Microarray Platform for Rapid, Low‐Cost Expanded Carrier Screening
Open Access
- 9 July 2026
- journal article
- Published by Wiley in Prenatal Diagnosis
Abstract
Objective: To develop a customized expanded carrier screening (ECS) solution for 8271 variants of 265 genes. Based on a microarray platform, this solution demonstrates comparable accuracy to next‐generation sequencing (NGS) platform; however, it has a lower cost, a faster speed, and a simplified data—analysis process. Method: A dedicated panel composed of 8271 variants of 265 high—priority genes was developed for custom microarray fabrication. To test the performance of the custom microarray, we selected 1051 blood samples from an NGS‐based ECS project to conduct a blind test. The evaluation indicators include sensitivity, specificity and positive predictive value. Results: 582 variants were identified in 69 genes. The concordance between the microarray platform and NGS platform results reaches 99.5%. The microarray demonstrated high sensitivity (99.8%) and specificity (99.8%), showing excellent performance in both positive and negative samples. The microarray platform reduces testing cycles to 3–4 days and lowers costs by 94%–96%. Conclusion: This study confirms that microarray‐based carrier screening is a reliable, cost‐effective, and timely alternative to NGS, and it is especially suitable for large‐scale population screening.Keywords
Funding Information
- National Key Research and Development Program of China (2024YFC2707000)
- National Key Research and Development Program of China (2021YFC1005301)
This publication has 18 references indexed in Scilit:
- International perspectives on the implementation of reproductive carrier screeningPrenatal Diagnosis, 2019
- Attitudes of the general population towards preconception expanded carrier screening for autosomal recessive disorders including inborn errors of metabolismMolecular Genetics and Metabolism, 2019
- Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough SolutionsValue in Health, 2018
- Implementing comprehensive genetic carrier screening in China―Harnessing the power of genomic medicine for the effective prevention/management of birth defects and rare genetic diseases in ChinaPediatric Investigation, 2018
- Expanded carrier screening for monogenic disorders: where are we now?Prenatal Diagnosis, 2017
- Carrier screening by next‐generation sequencing: health benefits and cost effectivenessMolecular Genetics & Genomic Medicine, 2016
- Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effectsEuropean Journal of Human Genetics, 2015
- Validation for Clinical Use of, and Initial Clinical Experience with, a Novel Approach to Population-Based Carrier Screening using High-Throughput, Next-Generation DNA SequencingThe Journal of Molecular Diagnostics, 2014
- Next-generation carrier screeningGenetics in Medicine, 2014
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesThe American Journal of Human Genetics, 2010